Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients ...

Discover a study where patients reported symptom relief as early as one week after starting treatment, with continued ...

Why are trials of de-escalation of therapy being conducted for early-stage breast cancer? Axillary nodal status in invasive breast cancer has long been regarded as one of the most important ...

Principles of axillary malodor formation in adults are well-known. However, no one has yet directly compared the chemical ...

Detailed price information for Dermata Therapeutics Inc WT (DRMAW-Q) from The Globe and Mail including charting and trades.